CytoMed Therapeutics
GDTC
#10921
Rank
$10.38 M
Marketcap
$0.87
Share price
7.22%
Change (1 day)
-54.92%
Change (1 year)

Financial Statements

Thumbnail CytoMed Therapeutics Financial Statement 2025

Financial Statement 2025

Language: English

View Financial Statement
Thumbnail CytoMed Therapeutics Financial Statement 2024

Financial Statement 2024

Language: English

View Financial Statement
Thumbnail CytoMed Therapeutics Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement